Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / American Depositary Shares, each representing one ordinary share, par value $0.000042 per share
-
Shares outstanding
-
265,957,447
-
Total 13F shares
-
25,076,258
-
Share change
-
-302,248
-
Total reported value
-
$164,226,984
-
Put/Call ratio
-
75%
-
Price per share
-
$6.55
-
Number of holders
-
55
-
Value change
-
-$2,136,433
-
Number of buys
-
30
-
Number of sells
-
32
Institutional Holders of Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) as of Q3 2021
As of 30 Sep 2021,
Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,076,258 shares.
The largest 10 holders included
FRAZIER MANAGEMENT LLC, Capital World Investors, Nantahala Capital Management, LLC, Polygon Management Ltd., CITADEL ADVISORS LLC, SCHRODER INVESTMENT MANAGEMENT GROUP, FMR LLC, Pendal Group Ltd, JPMORGAN CHASE & CO, and Alphabet Inc..
This page lists
55
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.